Literature DB >> 23978697

Type 2 ryanodine receptor domain A contains a unique and dynamic α-helix that transitions to a β-strand in a mutant linked with a heritable cardiomyopathy.

Fernando J Amador1, Lynn Kimlicka, Peter B Stathopulos, Geneviève M C Gasmi-Seabrook, David H Maclennan, Filip Van Petegem, Mitsuhiko Ikura.   

Abstract

Ryanodine receptors (RyRs) are large tetrameric calcium (Ca(2+)) release channels found on the sarcoplasmic reticulum that respond to dihydropyridine receptor activity through a direct conformational interaction and/or indirect Ca(2+) sensitivity, propagating sarcoplasmic reticulum luminal Ca(2+) release in the process of excitation-contraction coupling. There are three human RyR subtypes, and several debilitating diseases are linked to heritable mutations in RyR1 and RyR2 including malignant hypothermia, central core disease, catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia type 2 (ARVD2). Despite the recent appreciation that many disease-associated mutations within the N-terminal RyRABC domains (i.e., residues 1-559) are located in the putative interfaces mediating tetrameric channel assembly, the precise structural and dynamical consequences of the mutations are not well understood. We used solution nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography to examine the effect of ARVD2-associated (i.e., R176Q) and CPVT-associated [i.e., P164S, R169Q and delta exon 3 (Δ3)] mutations on the structure and dynamics of RyR2A. Our solution NMR data exposed a mobile α-helix, unique to type 2; further, this α2 helix rescues the β-strand lost in RyR2A Δ3 but remains dynamic in the hot-spot loop (HS-loop) P164S, R169Q and R176Q mutant proteins. Docking of our X-ray crystal/NMR hybrid structure into the RyR1 cryo-electron microscopy map revealed that this RyR2A α2 helix is in close proximity to dense "columns" projecting toward the channel pore. This is in contrast to the HS-loop mutations that cause structural changes largely localized to the intersubunit interface between adjacent ABC domains. Taken together, our data suggest that ARVD2 and CPVT mutations have at least two distinct structural consequences linked to channel dysfunction: perturbation of the HS-loop (i.e., domain A):domain B intersubunit interface and disruption of the communication between the N-terminal region and the channel domain.
© 2013.

Entities:  

Keywords:  ARVD2; CPVT; CSI; CSP; HS-loop; HSQC; NMR; NOE; TROSY; arrhythmogenic right ventricular dysplasia type 2; calcium channel; catecholaminergic polymorphic ventricular tachycardia; chemical shift index; chemical shift perturbation; cryo-EM; cryo-electron microscopy; crystallography; disease mutation; heteronuclear single quantum coherence; hot-spot loop; nuclear Overhauser enhancement; protein dynamics; transverse relaxation optimized spectroscopy

Mesh:

Substances:

Year:  2013        PMID: 23978697     DOI: 10.1016/j.jmb.2013.08.015

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Roles of the NH2-terminal domains of cardiac ryanodine receptor in Ca2+ release activation and termination.

Authors:  Yingjie Liu; Bo Sun; Zhichao Xiao; Ruiwu Wang; Wenting Guo; Joe Z Zhang; Tao Mi; Yundi Wang; Peter P Jones; Filip Van Petegem; S R Wayne Chen
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

2.  The Cytoplasmic Region of Inner Helix S6 Is an Important Determinant of Cardiac Ryanodine Receptor Channel Gating.

Authors:  Bo Sun; Wenting Guo; Xixi Tian; Jinjing Yao; Lin Zhang; Ruiwu Wang; S R Wayne Chen
Journal:  J Biol Chem       Date:  2016-10-27       Impact factor: 5.157

Review 3.  Structural Insight Into Ryanodine Receptor Channelopathies.

Authors:  Hadiatullah Hadiatullah; Zhao He; Zhiguang Yuchi
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

4.  Verapamil suppresses cardiac alternans and ventricular arrhythmias in acute myocardial ischemia via ryanodine receptor inhibition.

Authors:  Yu-Lei Deng; Jun-Yan Zhao; Ji-Hua Yao; Qiang Tang; Le Zhang; Hong-Lian Zhou; Cun-Tai Zhang; Jia-Gao Lv; Xiao-Qing Quan
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

5.  Structural insights into the human RyR2 N-terminal region involved in cardiac arrhythmias.

Authors:  Lubomír Borko; Vladena Bauerová-Hlinková; Eva Hostinová; Juraj Gašperík; Konrad Beck; F Anthony Lai; Alexandra Zahradníková; Jozef Sevčík
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-10-23

6.  Unreported intrinsic disorder in proteins: Building connections to the literature on IDPs.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2014-12-12

7.  Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant.

Authors:  Zhiguang Yuchi; Siobhan M Wong King Yuen; Kelvin Lau; Ainsley Q Underhill; Razvan L Cornea; James D Fessenden; Filip Van Petegem
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

8.  The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.

Authors:  Zhichao Xiao; Wenting Guo; Siobhan M Wong King Yuen; Ruiwu Wang; Lin Zhang; Filip Van Petegem; S R Wayne Chen
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

9.  Generation and characterization of a mouse model harboring the exon-3 deletion in the cardiac ryanodine receptor.

Authors:  Yingjie Liu; Ruiwu Wang; Bo Sun; Tao Mi; Jingqun Zhang; Yongxin Mu; Ju Chen; Michael J Bround; James D Johnson; Anne M Gillis; S R Wayne Chen
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

Review 10.  Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review.

Authors:  Siobhan Simpson; Paul Rutland; Catrin Sian Rutland
Journal:  Vet Sci       Date:  2017-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.